Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years

“The lack of findings thus far in the Baby’s First Years study should not be used to justify actions that will further hurt children’s developmental h...

Disaster response systems are woefully unprepared to address long-term neurological health impacts.

Kelvin Droegemeier, a Trump adviser in his first term, is leading an effort to offer an alternative to the administration’s plan for reshaping federal...

WASHINGTON — President Trump may aggressively negotiate lower drug prices in Medicare using a program that Democrats created and Trump rarely mentions...

With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the model is unlikely to signif...

In a highly unusual move, a small biotech has disclosed a rejection letter from the FDA in hopes of rallying support for regulatory approval of an ult...

Plus more health news stories of the day.

An experimental Pfizer sickle cell treatment failed to meet the main goal in a late-stage trial for patients aged 16 and older

And other biotech news stories, brought to you by The Readout.